|

E7 TCR-T cells Clinical Trials

2 actively recruiting trials across 2 locations

Also known as: Adoptive cell transfer, CAR-T, E7 TCR, HPV TCR, TCR +1 more

Pipeline

Phase 2: 1Phase 1/2: 1

Top Sponsors

  • Christian Hinrichs2

Indications

  • HPV-Related Vulvar Squamous Cell Carcinoma2
  • HPV-Related Penile Squamous Cell Carcinoma2
  • HPV-Related Anal Squamous Cell Carcinoma2
  • HPV-Related Endocervical Adenocarcinoma2
  • HPV-Related Adenosquamous Carcinoma2

Bethesda, Maryland1 trial

E7 TCR-T Cell Immunotherapy for Human Papillomavirus (HPV) Associated Cancers

National Institutes of Health Clinical Center

Phase 2

New Brunswick, New Jersey1 trial

E7 T-cell Receptor (TCR) -T Cell Induction Therapy for Locoregionally Advanced HPV-associated Cancers

Rutgers Cancer Institute

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.